Skip to main navigation
VivoSim Labs, Inc. homepage
  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact

SEC Filing Details

  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact

Document Details

Form
CORRESP
Filing Date
Mar 30, 2026
Document Date
Mar 30, 2026
Form Description
CORRESP
Filing Group
Other
Company
VivoSim Labs, Inc.
Issuer
VIVOSIM LABS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

© VivoSim Labs, Inc. 2026 | Contact Us

VivoSim Labs, Inc. homepage
  • Technology
    • NAMkind™ Intestine Model
    • NAMkind™ Liver Model
  • Services
    • Gastrointestinal Toxicology Services
    • Investigative Toxicology Services
    • Liver Toxicology Services
  • Company
    • About
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Press Releases
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor Alerts
    • Investor Contacts
    • Investor Presentations
  • Contact